DENVER—In the current era of nuclear stress testing, a major debate is whether pharmalogical stress testing is comparable with exercise testing. During a presentation Sept. 11 at the 16th annual American Society of Nuclear Cardiology (ASNC) scientific sessions, Brian G. Abbott, MD, medical director of nuclear cardiology at the Rhode Island Cardiology Center in Providence, R.I., said yes, particularly for diagnosing coronary artery disease.
Written by Kaitlyn Dmyterko
DENVER—With the “explosive growth” of cardiovascular imaging, the focus must now center on improving quality and reducing radiation exposure, and appropriate use criteria (AUC) can help, Robert C. Hendel, MD, director of cardiac imaging and outpatient services at the University of Miami Miller School of Medicine in Miami, said during a presentation Sept. 10 at the 16th annual American Society of Nuclear Cardiology (ASNC) scientific sessions.
Written by Kaitlyn Dmyterko
DENVER—Incorporating coronary artery calcium screening (CAC) into practice can change the diagnoses and management of coronary artery disease (CAD), however, it may still be too early to tell how it will impact patient outcomes, Tim M. Bateman, MD, co-director of cardiovascular radiologic imaging at Mid America Heart Institute, Saint Luke's Health System in Kansas City, said during a presentation Sept. 11 at the 16th annual American Society of Nuclear Cardiology (ASNC) scientific session.
Written by Kaitlyn Dmyterko
DENVER—Coronary CT Angiography (CCTA) is not indicated for use in atrial fibrillation (AF) patents due to the problems it causes in terms of diagnostic accuracy, Thomas C. Gerber, MD, PhD, of the division of cardiovascular diseases at the Mayo Clinic, Jacksonville, Fla., said during a presentation Sept. 10 at the annual scientific sessions of the American Society of Nuclear Cardiology (ASNC). However, cardiac CT may be beneficial in some instances for this patient population when the right methods are used.
Written by Kaitlyn Dmyterko
DENVER—When performing nuclear imaging studies, it is important to balance benefits against potential risks, however, it is most imperative to ensure that only appropriate patients are being imaged, George A. Beller, MD, a cardiologist at the University of Virginia Health System in Charlottesville, said during a presentation Sept. 10 at the 16th annual American Society of Nuclear Cardiology (ASNC) scientific session.
Written by Kaitlyn Dmyterko
DENVER—“Anatomy or ischemia: Will either one of these add to better outcomes?” asked James E. Udelson, MD, chief of the division of cardiology and director of nuclear cardiology laboratory at the Tufts Medical Center in Boston, during a presentation Sept. 9 at this year's American Society of Nuclear Cardiology (ASNC) scientific sessions.
DENVER—As important players within the medical community work to reduce unnecessary radiation exposure from medical imaging, integrating protocols and strategies, such as shielding, can help reduce dose, James A. Case, PhD, of Cardiovascular Imaging Technologies in Kansas City, said during a presentation Sept. 9 at the 16th annual American Society of Nuclear Cardiology (ASNC) meeting.
Written by Leslee J. Shaw, PhD, FASNC
The 16th annual scientific session of the American Society of Nuclear Cardiology (ASNC), Sept. 8-11, brings together scientists, clinicians and industry to establish and discuss optimal standards of imaging care.
The American Society of Nuclear Cardiology has appointed Kathleen B. Flood as its Chief Executive Officer, effective June 1, 2011.
Written by C.P. Kaiser
SPECT myocardial perfusion imaging (MPI) is a well-validated noninvasive test to determine if coronary artery disease (CAD) is the cause of a patient’s chest pain. While SPECT will continue to play a role in this patient population, other tests are helping to fill in the gaps in identifying those at risk of cardiac events.
Written by Kaitlyn Dmyterko
Due to the commonality of these arrhythmias and the number of procedures necessary to treat them, there is a growing need for the field of electrophysiology (EP). And to better treat patients with dangerous arrhythmias, practitioners have begun using cardiac PET and SPECT to help in patient selection and to guide EP procedures including ablations, lead placements and CRT implantations.
Written by Kaitlyn Dmyterko
To achieve the American Society of Nuclear Cardiology’s (ASNC) 2014 goal of having the total radiation exposure for patients referred for SPECT/PET myocardial perfusion imaging to be equal to or lower than 9 mSv in 50 percent of studies, nuclear cardiologists must focus on appropriate patient selection and assessing protocols, radiotracers and imaging systems, said Manuel D. Cerqueira, MD, chairman of the department of nuclear medicine at the Cleveland Clinic, during a webinar Feb. 17 sponsored by the ASNC.
|
RSS 
